Answer
Intravenous Herceptin (trastuzumab) has no constant half-life because non-linear elimination causes total clearance to increase as its concentration decreases, so its half-life decreases as concentrations fall within a dosing interval.
Sources for this answer
- Herceptin 150mg Powder for concentrate for solution for infusionRoche Products Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 52Document updated
Sources checked